Generics BulletinPreviously facing the prospect of a jury trial beginning next month, Jazz Pharmaceuticals has agreed in principle to pay $145m to resolve certain allegations that its US patent-litigation settlement a
Generics BulletinAmneal says the planned portfolio of its glucagon-like peptide-1 (GLP-1) agonist collaboration partner Metsera is “moving swiftly through the drug development phase,” as the US-based firm noted that t
Pink SheetAfter another loss in the US Court of Appeals, Teva will seek a certiorari review by the US Supreme Court of its long-running inhaler patent case against Amneal . Teva had requested a full panel re
Generics BulletinTeva has suffered another nth blow in its long-running inhaler patent case against Amneal, as the US Court of Appeals for the Federal Circuit denied the Israeli firm’s request for an en banc reheari